Infectious DiseaseUrology
Recurrent UTI in Women
≥2 UTI in 6 months / ≥3 in 12 months — investigation + non-antibiotic + antibiotic prevention strategies.
Source: NICE NG112 / CKS; EAU 2024
Step 1 of ~3
info
Define + Investigate
Recurrent UTI: ≥2 episodes in 6 months OR ≥3 in 12 months. Confirm with MSU + culture (clean-catch).
Investigate red flags requiring referral: visible haematuria, suspicion of malignancy / obstruction, pyelonephritis, structural / functional abnormality, abnormal renal function.
• Urinalysis + cultures during episodes.
• Bladder diary, voiding pattern.
• Post-void residual (USS bladder).
• Sexual / contraceptive history; menopause status.
• Imaging USS / CT-IVU + cystoscopy if red flags or atypical organisms.
• Glucose for diabetes; consider immunodeficiency screening if recurrent / atypical organisms.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Doxycycline 100mg (Acne / Rosacea) · Oral tetracycline antibiotic (anti-acne / anti-rosacea)
- Lymecycline 408mg (Acne) · Oral tetracycline antibiotic (anti-acne)
- Erythromycin 2% Topical · Topical macrolide antibiotic (anti-acne)
- Mupirocin 2% Ointment · Topical antibiotic (pseudomonic acid)
- Fusidic Acid 2% Cream · Topical antibiotic (steroidal antibiotic)
- Metronidazole Topical · Topical Antibiotic/Antiprotozoal — Rosacea
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023
Decision support only. Always apply local guidelines and clinical judgement.